Related Experiment Video
Updated: Feb 12, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Surveillance of sexualised drug use - the challenges and the opportunities
Isabelle Giraudon1, Axel Jeremias Schmidt2, Hamish Mohammed3
1Trends and Analysis Sector, Public Health Unit, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Praça Europa 1, Cais do Sodré, 1249-289 Lisbon, Portugal.
Abstract:
Sexualised drug use (SDU), the use of drugs in a sexual context, has emerged as a marker of high-risk sexual activity and poor sexual health among gay, bisexual and other men who have sex with men, however, there are no robust estimates of the prevalence of SDU. The primary sources of surveillance data on SDU should include both sexual health and drug treatment services. The challenges to achieving comprehensive, timely and valid SDU surveillance include establishing case definitions, selecting appropriate surveillance settings, and normalising the monitoring of SDU at clinical services. In this commentary we propose a means to address these challenges and discuss other sources of SDU data from ad hoc population surveys and sentinel systems. We also present case studies of SDU surveillance development in England and Switzerland. The patterns of SDU will be affected by a rapidly changing drug market and, as a result, surveillance systems must continuously adapt to ensure that they are fit for purpose and can provide data to guide policy.
Related Concept Videos
Principles of Disease Surveillance
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Drug toxicity: Drug–Drug Interaction
Pharmacokinetics: Drug–Drug Interactions
Bioequivalence of Drugs: Drugs with Multiple Indications
FDA Approved Drugs: Changes to Approved Drugs

